Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
My north star: We disclose—fast, fully, and on our terms. The “wait for more data” option is a mirage. It exposes the company to criminal liability under FDA adverse-event reporting rules, potential DOJ investigation, securities fraud charges, and derivative litigation that could destroy the firm.Read the full answer
Goal: Protect patients, meet legal/ethical obligations, preserve the company’s long‑term credibility, and manage the immediate financial and reputational fallout. Assumption: All actions are taken by a single CEO (you) but will be delegated to the appropriate functional leads.Read the full answer